Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2008
08/05/2008US7408027 Epitopes of the tau protein which are specifically occurring in a phosphorylated state in tau protein from Alzheimer paired helical filaments; for the generation of antibodies specifically detecting Alzheimer tau protein; for testing drugs effective in dissolving Alzheimer paired helical filaments
08/05/2008US7408024 Somatostatin antagonists
08/05/2008US7407943 Comprises oligonucleotide which targets apolipoprotein nucleotide sequences and prevents expression; gene expresion inhibition; diagnosis and treatment of cardiovascular, infectious, hyperlipidemic and atherosclerotic disorders
08/05/2008US7407805 Keratinocytes and culture medium containing ascorbic and linoleic acid, vitamin e, epidermal growth factor; has surface electrical capacitance of given values
08/05/2008US7407804 Nucleic acid of given sequence with cytosine to thymine substitution; expression vectors; gene therapy for Chronic Obstructive Lung Disease, Adult Respiratory Distress Syndrome, and asthma
08/05/2008US7407803 Immunogenic composition comprising bacterial or viral vector, antigen and toxins; escherichia and baculovirus; vaccines
08/05/2008US7407802 Plasmid comprising nucleotide sequences coding vaccine specific to newcastle disease virus hemagglutinin-neuraminidase (HN) for use in prevention and treatment of viral diseases in plants
08/05/2008US7407791 cell comprising a peptide transport operon mutated such that said cell has increased polypeptide secretion
08/05/2008US7407785 Human DNase I hyperactive variants
08/05/2008US7407777 IL-2 transmembrane construct
08/05/2008US7407771 modulation of apoptosis or inflammatory processes, by transfection of cells with nucleotide sequences that code for proteins, fragments or isoforms capable of binding to or interacting directly or indirectly with death domains and/or binding proteins
08/05/2008US7407770 Which bind specifically to polypeptides; microtiter plate and enzyme linked immunosorbent assay; diagnosis and treatment of canine and human ehrlichiosis
08/05/2008US7407766 Screening method for agonists or antagonists of semaphorin 6C by determining the effect of a test compound on the interaction between semaphorin 6C and plexin-A1
08/05/2008US7407751 Methods for the detection and prognosis of breast tumors
08/05/2008US7407677 Nucleotide sequences coding hydrolases for use in cleaning agents, detergents, textile treatment, baking, inking recycled paper, animal feeds, beverages and in the oilfield industry
08/05/2008US7407672 Serum and a gelling agent such as gelatin, may further comprise an anticoagulant such as heparin
08/05/2008US7407475 Modified annexin proteins, and methods and compositions for using them
08/05/2008CA2355845C Diacylglycerol acyltransferase gene from plants
08/05/2008CA2347960C A method of affinity separation and ligands for use therein
08/05/2008CA2343575C Inhibition of smooth muscle cell migration by heme oxygenase 1
08/05/2008CA2340888C Novel tumor antigen protein sart-3 and tumor antigen peptide thereof
08/05/2008CA2306188C A novel method for the integration of foreign dna into eukaryotic genomes
08/05/2008CA2286482C Nkt cell-activating agents containing .alpha.-glycosylceramides
08/05/2008CA2259640C Human glycine transporter
08/05/2008CA2161808C Bmp-11 compositions
08/05/2008CA2124673C Fatty acid desaturase genes from plants
08/05/2008CA2120514C Synthetic dna sequence having enhanced insecticidal activity in maize
07/2008
07/31/2008WO2008092002A2 Compositions and methods for treating and diagnosing pancreatic cancer
07/31/2008WO2008091908A2 Human cancer stem cells
07/31/2008WO2008091830A2 Maintenance and propagation of mesenchymal stem cells
07/31/2008WO2008091013A1 Method for preparation of cartilage cell
07/31/2008WO2008090960A1 Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
07/31/2008WO2008090959A1 Genetically recombinant antibody composition having enhanced effector activity
07/31/2008WO2008090958A1 Domain-exchanged recombinant antibody composition
07/31/2008WO2008090937A1 Apparatus and method for introducing substance into cells
07/31/2008WO2008090826A1 Method for production of mesenchymal cell, method for production of tooth, and mesenchymal cell for formation of tooth
07/31/2008WO2008090678A1 Novel peptide
07/31/2008WO2008090501A1 Process for treating cultured cells
07/31/2008WO2008090290A2 Chemically defined synthetic culture medium
07/31/2008WO2008090224A1 Method for inducing thrombopoiesis
07/31/2008WO2008089567A1 Cancerous disease modifying antibodies
07/31/2008WO2008089566A1 Cancerous disease modifying antibodies
07/31/2008WO2008089565A1 Cancerous disease modifying antibodies
07/31/2008WO2008089558A1 Abap1 docking protein
07/31/2008WO2008073577A3 Electronic and biological pacemaker systems
07/31/2008WO2008068776A3 Three-dimensional tissue equivalent using macromass culture.
07/31/2008WO2008061148A9 Methods and compositions for cryopreserving oocytes
07/31/2008WO2008051797A3 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
07/31/2008WO2008015682A3 Methods of expanding embryonic stem cells in a suspension culture
07/31/2008WO2007147014A3 Method and systems for using biopolymer-based beads and hydrogels
07/31/2008WO2007141657B1 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
07/31/2008WO2007106868A3 Cell culture devices having ultrathin porous membrane and uses thereof
07/31/2008WO2007106596A3 Human liver cancer cell line
07/31/2008WO2007095594A3 Methods and compositions for enhancing engraftment of hematopoietic stem cells
07/31/2008WO2006104609A3 Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
07/31/2008WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof
07/31/2008WO2001044293A8 Sodium channel proteins
07/31/2008US20080184397 Acquired Resistance Genes in Plants
07/31/2008US20080184395 overexpressing a molybdenum cofactor sulfurase in Arabidopsis thalania; improving drought resistance, freeze resistance, salt tolerance of plants
07/31/2008US20080184392 Transforming a plant cell with a nucleic acid sequence that encodes the acquired resistance polypeptide, regenerating a plant from the transformed plant cell; resistance to fungal pathogens
07/31/2008US20080184390 Expression cassettes for mesophyll-and/or epidermis-preferential expression in plants
07/31/2008US20080184389 Maize promoter p95 and methods of use
07/31/2008US20080184388 Zea mays provides a high level of specificity for expression in developing pollen; plants comprising suppressed male fertility genes, useful as females in hybrid plant production; useful for generating fertile parental plants that, when crossed generate sterile progeny plants
07/31/2008US20080184387 in plants obtainable from Arabidopsis thaliana genes; for alteration of the function of root tissue, modification of growth rate, improvement of resistance to root preferred pathogens, pests, herbicides or adverse weather conditions, for detoxification of soil as well as for broadening the range of soils
07/31/2008US20080184382 homozygous for the dark green gene, producing fruit comprising an average lycopene content at least two fold content in fruit of currently available commercial tomato; devoid of the undesired pleiotropic effects associated with the dg mutation
07/31/2008US20080184381 Schizophrenia-related voltage-gated ion channel gene and protein
07/31/2008US20080182977 Molecules associated with cell proliferation
07/31/2008US20080182976 kit for detecting erythropoietin receptors which is capable of being activated comprising an antibody or fragment which activates formation or production of erythrocytes; treatment of anemia
07/31/2008US20080182864 2-(1-Aroylaminoalkyl)-3-(alkylaryl)-7-(halo- or cyano)quinazolinone derivatives, e.g., 2-[1'-(N,N-dimethylethylenediamino)propyl]-3-benzylquinazolin-4-one; mitotic kinesin spindle protein inhibitors; disrupting mitosis; modulating mitotic spindle formation; restenosis
07/31/2008US20080182835 Cobalt attached/coordinated to 6 same or different ligands including a N-based ligand donor atom that is ammonia, primary amine or secondary amine, or salt; does not have free cobalt(III) coordination sites and does not hydrolyze oligonucleotides; complex may be bound to an oligonucleotide
07/31/2008US20080182818 Th1 CELL DIFFERENTIATION ACCELERATOR
07/31/2008US20080182808 Capable of inducing breakdown of mrna enzymes that break down connective tissue; particularly suited for treating degenerative skin disorders; pharmaceutical and cosmetic compositions for topical application and which contain the oligoribonucleotides
07/31/2008US20080182807 gene therapy against tumors and cancer; expression vector includes insert into tumor an effective amount of polynucleotides encoding a functionally active p53, express p53 to first DNA damaging agent, contact tumor cell with first DNA damaging agent, and kill tumor cell
07/31/2008US20080182793 Polypeptide comprising oxidized lipid and/or carbohydrate binding activity for use as tool in diagnosis, prevention and treatment of thrombosis, atherosclerosis, inflammatory and bone disorders
07/31/2008US20080182788 Compositions and Methods for Increasing Bone Mineralization
07/31/2008US20080182786 Target protein is supported on carrier made from a clay mineral, and by adding this to cells it is possible to introduce the target protein into the cells; clay mineral is preferably a layered clay mineral such as montmorillonite, vermiculite, and illite
07/31/2008US20080182753 Polynucleotide molecule isolated or identified from Oryza sativa (rice); for expressing transgenes in plants, root tissues
07/31/2008US20080182332 Optimized non-canonical zinc finger proteins
07/31/2008US20080182331 Production of transgenic animals; targeted replacement of an endogenous gene; genetic trait expression; DNA gene inactivation construct
07/31/2008US20080182329 Methods and products related to metabolic interactions in disease
07/31/2008US20080182328 Mammalian extraembryonic endoderm cells and methods of isolation
07/31/2008US20080182327 cells containing proteic killer system based on the E. coli RelE polypeptide; gene coding for the antidote polypeptide is operably linked to a regulatory sequence that is different from the regulatory sequence controlling the gene coding for the cytotoxin polypeptide
07/31/2008US20080182319 nucleotide sequence encoding a specific binding member or antibody VH or VL domain of a specific binding member that binds human eotaxin chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens; host cell
07/31/2008US20080182316 Nucleic acids encoding opiate receptors
07/31/2008US20080182314 Neuronal serine threonine protein kinase
07/31/2008US20080182297 Medium for the protein-free and serum-free cultivation of cells
07/31/2008US20080182295 Apparatus and methods for osmotically shocking cells
07/31/2008US20080182281 detection sensitivity comparable to that in a conventional determination method, easy to handle a sample after collection, and highly reproducible measurements; diagnoses, monitoring of the treatment, monitoring of recurrence, or the like of various diseases including small cell lung cancer
07/31/2008US20080182279 Bacillus crystal protein having improved insecticidal activity; transgenic plant; polynucleotide segment having a sequence region that encodes an insecticidal hybrid delta-endotoxin protein; immunoassay
07/31/2008US20080182278 Identification and isolation of transitional cell carcinoma stem cells
07/31/2008US20080182276 Method and Quantification Assay for Determining c-kit/SCF/pAKT Status
07/31/2008US20080182275 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/31/2008US20080182274 Measuring simply and rapidly the expression of membrane protein on cell membrane; promotion/inhibition of the expression of membrane proteins
07/31/2008US20080182269 utilize promoter hairpin constructs to suppress gene expression and thereby identify function of a gene of interest; useful for generating fertile parental plants that when crossed generate sterile progeny plants
07/31/2008US20080182268 Schizophrenia associated genes, proteins and biallelic markers
07/31/2008US20080182267 Method for predicting a drug transport capability by abcg2 polymorphisms
07/31/2008US20080182266 Trp8, a transient receptor potential channel expressed in taste receptor cells
07/31/2008US20080182250 Method for detecting multiple myeloma and method for inhibiting the same
07/31/2008US20080182242 Dominant-negative alleles of human mismatch repair genes can be used to generate hypermutable cells and organisms. By introducing these genes into mammalian cells new cell lines with novel and useful properties can be prepared more efficiently than by relying on the natural rate of mutation
07/31/2008US20080181954 Genetically altered chondrocyte expresses a therapeutic agent; implanting a biocompatible substrate into a target region; brain, heart, liver, kidney, intestinal tract, spleen, smooth and skeletal muscles, eye, ganglions, lungs, gonads, pancreas